Target Price | $643.26 |
Price | $487.43 |
Potential | 31.97% |
Number of Estimates | 19 |
19 Analysts have issued a price target Synopsys 2026 . The average Synopsys target price is $643.26. This is 31.97% higher than the current stock price. The highest price target is $699.00 43.41% , the lowest is $540.00 10.79% . | |
A rating was issued by 23 analysts: 21 Analysts recommend Synopsys to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Synopsys stock has an average upside potential 2026 of 31.97% . Most analysts recommend the Synopsys stock at Purchase. |
19 Analysts have issued a sales forecast Synopsys 2025 . The average Synopsys sales estimate is $6.8b . This is 8.24% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $6.8b 9.19% , the lowest is $6.8b 7.80% .
This results in the following potential growth metrics:
2024 | $6.1b | 14.95% |
---|---|---|
2025 | $6.8b | 10.68% |
2026 | $7.7b | 13.02% |
2027 | $8.7b | 13.34% |
2028 | $9.5b | 9.67% |
2029 | $9.9b | 3.95% |
10 Analysts have issued an Synopsys EBITDA forecast 2025. The average Synopsys EBITDA estimate is $2.9b . This is 69.35% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.0b 78.39% , the lowest is $2.8b 65.12% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $1.9b | 12.12% |
---|---|---|
2025 | $2.9b | 50.46% |
2026 | $3.4b | 16.28% |
2027 | $3.9b | 17.25% |
2028 | $4.5b | 15.12% |
2024 | 31.31% | 2.46% |
---|---|---|
2025 | 42.56% | 35.94% |
2026 | 43.79% | 2.89% |
2027 | 45.30% | 3.45% |
2028 | 47.55% | 4.97% |
11 Synopsys Analysts have issued a net profit forecast 2025. The average Synopsys net profit estimate is $1.6b . This is 28.39% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.7b 26.14% , the lowest is $1.4b 36.16% .
This results in the following potential growth metrics and future Net Margins:
2024 | $2.2b | 83.21% |
---|---|---|
2025 | $1.6b | 28.34% |
2026 | $1.9b | 17.44% |
2027 | $2.4b | 26.06% |
2028 | $2.8b | 18.97% |
2024 | 36.51% | 59.38% |
---|---|---|
2025 | 23.64% | 35.25% |
2026 | 24.56% | 3.89% |
2027 | 27.32% | 11.24% |
2028 | 29.63% | 8.46% |
11 Analysts have issued a Synopsys forecast for earnings per share. The average Synopsys <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $10.40 . This is 28.37% lower than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $10.72 26.17% , the lowest is $9.27 36.16% .
This results in the following potential growth metrics and future valuations:
2024 | $14.51 | 83.21% |
---|---|---|
2025 | $10.40 | 28.33% |
2026 | $12.21 | 17.40% |
2027 | $15.39 | 26.04% |
2028 | $18.31 | 18.97% |
Current | 33.56 | 46.11% |
---|---|---|
2025 | 46.88 | 39.69% |
2026 | 39.92 | 14.85% |
2027 | 31.67 | 20.67% |
2028 | 26.62 | 15.95% |
Based on analysts' sales estimates for 2025, the Synopsys stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 10.62 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 11.12 .
This results in the following potential growth metrics and future valuations:
Current | 11.50 | 9.38% |
---|---|---|
2025 | 10.62 | 7.63% |
2026 | 9.40 | 11.52% |
2027 | 8.29 | 11.77% |
2028 | 7.56 | 8.82% |
2029 | 7.27 | 3.80% |
Current | 12.03 | 6.29% |
---|---|---|
2025 | 11.12 | 7.61% |
2026 | 9.83 | 11.52% |
2027 | 8.68 | 11.77% |
2028 | 7.91 | 8.82% |
2029 | 7.61 | 3.80% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.